Survival and perioperative outcomes of pelvic exenteration in primary advanced and recurrent endometrial carcinoma: A systematic review and meta-analysis
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110436 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Antonio Raffone und 13 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Gynaecology and Obstetrics, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80168,…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Pelvic Exenteration, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: To assess survival and perioperative complications and mortality of pelvic exenteration (PE) in recurrent and advanced endometrial carcinoma (EC) patients. METHODS: A systematic review and a meta-analysis was performed searching 7 electronic databases from their inception to May 2024 for all peer-reviewed studies that reported as a study outcome at least the 5 years-overall survival (OS) of PE in recurrent and/or advanced EC patients. Our outcomes were 5 year-OS from PE as primary outcome, and all extractable outcomes about PE survival [overall OS, 5 year- and overall disease specific survival (DSS), 5 year- and overall progression free survival (PFS)] and perioperative mortality and complications. Rates of survival outcomes and perioperative mortality and complications were calculated as individual and pooled estimates, with 95 % confidence intervals (CI). Subgroup analyses were planned for all study outcomes based on recurrent or advanced EC, separately. RESULTS: 6 studies with 166 patients were included. In women underwent PE for advanced or recurrent EC, pooled rate was: 41.7 % (95 % CI: 25.6-57.8 %) for 5 year-OS; 30.4 % (95 % CI: 14.9-45.8 %) for 5 year-DSS; 26.6 % (95 % CI: 10.6-42.5 %) for overall DSS; 51.8 % (95 % CI: 25.6-78.0 %) for 5 year-PFS; 9.7 % (95 % CI: 5.7-16.1 %) for perioperative mortality; 56.1 % (95 % CI: 32.3-76.4 %) for perioperative complications. Subgroup analyses were suitable exclusively in the "recurrent EC" subgroup and showed even worsened outcomes. CONCLUSIONS: In women with advanced or recurrent EC, PE shows not encouraging survival outcomes, with relatively high rates of perioperative mortality and complications. These outcomes further worsened in the subgroup of only recurrent EC. However, they should be confirmed by more updated studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Gynaecology and Obstetrics, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80168, Naples, Italy; Department of Medical and Surgical Sciences (DIMEC), U…
- Department of Medicine - University of Udine, Udine, Italy; Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
- Division of Gynecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Pathology Unit, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy.
- Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy. Electronic address: d.neola@outlook.com.
- UOC Gynecologic Oncology, Department of Women's and Children's Health Sciences and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Catholic University of the Sacred Heart, Rome,…
Zitieren
APA
Raffone, A., Pellecchia, G., Pregnolato, S., Raimondo, D., Travaglino, A., Neola, D., Driul, L., Fanfani, F., Arcieri, M., Vastarella, M. G., Restaino, S., Cobellis, L., Seracchioli, R., & Vizzielli, G. (2025). Survival and perioperative outcomes of pelvic exenteration in primary advanced and recurrent endometrial carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110436
Vancouver
Raffone A, Pellecchia G, Pregnolato S, Raimondo D, Travaglino A, Neola D, et al. Survival and perioperative outcomes of pelvic exenteration in primary advanced and recurrent endometrial carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110436
BibTeX
@article{Raffone2025,
author = {Raffone, Antonio and Pellecchia, Giulia and Pregnolato, Sara and Raimondo, Diego and Travaglino, Antonio and Neola, Daniele and Driul, Lorenza and Fanfani, Francesco and Arcieri, Martina and Vastarella, Maria Giovanna and Restaino, Stefano and Cobellis, Luigi and Seracchioli, Renato and Vizzielli, Giuseppe},
title = {Survival and perioperative outcomes of pelvic exenteration in primary advanced and recurrent endometrial carcinoma: A systematic review and meta-analysis},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110436}
}
EUVIMED